1h Free Analyst Time
Technavio has been monitoring the viral vectors market and is forar report on the viral vectors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic diseases, increasing use of viral vectors to develop gene therapies, and growing application of viral vectors in vaccine manufacturing.
The viral vectors market is segmented as below:
By Application
- Gene therapy
- Vaccines
By End-user
- Pharmaceutical and biotechnology companies
- Academics and research institutes
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the viral vectors market covers the following areas:
- Viral vectors market sizing
- Viral vectors market forecast
- Viral vectors market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global viral vectors market: Batavia Biosciences BV, Bayer AG, Catalent Inc., Creative Biogene, Danaher Corp., F. Hoffmann La Roche Ltd., FinVector Oy, FUJIFILM Holdings Corp., Institut Merieux, Lonza Group Ltd., Merck KGaA, Novartis AG, Oxford Biomedica Plc, REGENXBIO Inc, Sirion Biotech GmbH, Syncona Ltd., Takara Holdings Inc., Thermo Fisher Scientific Inc., uniQure NV, and Virovek Inc.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rapid growth potential of viral vectors in developing economies."
According to the report, one of the major drivers for this market is the rising prevalence of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Batavia Biosciences BV
- Bayer AG
- Catalent Inc.
- Creative Biogene
- Danaher Corp.
- F. Hoffmann La Roche Ltd.
- FinVector Oy
- FUJIFILM Holdings Corp.
- Institut Merieux
- Lonza Group Ltd.
- Merck KGaA
- Novartis AG
- Oxford Biomedica Plc
- REGENXBIO Inc
- Sirion Biotech GmbH
- Syncona Ltd.
- Takara Holdings Inc.
- Thermo Fisher Scientific Inc.
- uniQure NV
- Virovek Inc
